Mar 03, 2020 / NTS GMT
Unidentified Participant -
We'd like to begin. Thank you for joining the R&D meeting with Sumitomo Dainippon Pharma. Just for your information, this meeting is being broadcasted live and is telephonic. Today's presenters are Mr. Nomura, President and CEO of the company; Dr. Kimura, who will be presenting Psychiatry & Neurology area and Regenerative Medicine & Cell Therapy; Dr. Koshiya, who will be presenting Oncology area. And from the United States, we have Dr. Kenneth Koblan, Chief Scientific Officer in Sunovion Pharmaceuticals. I'm [Higuchi], a moderator.
We will be using the slide deck we sent out via e-mail. This is the agenda. Mr. Nomura will present the overview at the introduction, followed by the presentation on Psychiatry & Neurology area and then Regenerative Medicine & Cell Therapy by Dr. Kimura, followed by the presentation on Oncology area by Dr. Koshiya, followed by the presentation on SEP-363856 by Dr. Koblan. We will have a Q&A session at the end of the meeting. We can take questions from those who are joining on the phone.
Without further ado, I'd like to
Sumitomo Dainippon Pharma Co Ltd R&D Meeting Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot